Anthem Blue Cross Connecticut Commercial Clinical Policy

MED.00104 Non-invasive Measurement of Advanced Glycation End Products (AGEs) in the Skin Form

Chat with GenHealth to automate any policy or prior auth task.

Procedure is not covered

Effective Date

04/12/2023

Last Reviewed

02/16/2023

Original Document

Reference

This document addresses non-invasive measurement of advanced glycation end products (AGEs) in the skin via photospectroscopy. AGEs have been indicated as mediators of various vascular and cardiac complications in a wide variety of conditions, including diabetes, renal failure, and congestive heart failure.

Position Statement

Investigational and Not Medically Necessary:

Non-invasive measurement of advanced glycation end products (AGEs) in the skin is considered investigational and not medically necessary for all indications, including but not limited to diabetes, renal failure, and cardiac disease.

Book a walkthrough

Walk through this policy with us

Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.

GenHealth is the best way to run RCM including eligibility, prior auth, billing, and denials with AI that works like a teammate in your EMR and billing systems.

MED.00104 Non-invasive Measurement of Advanced Glycation End Products (AGEs) in the Skin Form

Procedure is not covered

Position Statement

Walk through this policy with us

Choose how you'd like to learn more.

GenHealth is the best way to run RCM including eligibility, prior auth, billing, and denials with AI that works like a teammate in your EMR and billing systems.

MED.00104 Non-invasive Measurement of Advanced Glycation End Products (AGEs) in the Skin Form

Procedure is not covered

Position Statement

Walk through this policy with us

Choose how you'd like to learn more.

Try GenHealth free.

Automate intake, eligibility, and PA with AI agents that work in your EMR and billing systems.